Acumen Pharmaceuticals, Inc. Proceeds from Issuance of Private Placement
Acumen Pharmaceuticals, Inc. (ABOS) reported Proceeds from Issuance of Private Placement of $35.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2026-06-30 was -$305.00K.
- Acumen Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2026-03-31 was $35.75M.
- Acumen Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2025-06-30 was $0.00.
- Acumen Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2025-03-31 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month |
|---|---|---|
| 2026-06-30 | -$305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $35.44M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $35.75M 10-Q · filed 2026-05-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |